{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T07:04:35Z","timestamp":1789715075294,"version":"4.0.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MedScience"],"DOI":"10.1007\/s11684-026-1232-0","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:50:45Z","timestamp":1789714245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ultra-rapid progression of MAFLD to cirrhosis and post-transplant steatosis in a patient with a polygenic risk profile"],"prefix":"10.1007","author":[{"given":"Zi-Ling","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Tong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"issue":"Suppl 2","key":"1232_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s12072-024-10704-3","volume":"18","author":"Y Fouad","year":"2024","unstructured":"Fouad Y, Alboraie M, Shiha G. Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease. Hepatol Int 2024; 18(Suppl 2): 827\u2013833","journal-title":"Hepatol Int"},{"issue":"Suppl 2","key":"1232_CR2","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1007\/s12072-024-10667-5","volume":"18","author":"V Moretti","year":"2024","unstructured":"Moretti V, Romeo S, Valenti L. The contribution of genetics and epigenetics to MAFLD susceptibility. Hepatol Int 2024; 18(Suppl 2): 848\u2013860","journal-title":"Hepatol Int"},{"issue":"2","key":"1232_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam M, Valenti L, Romeo S. Genetics and epigenetics of NAFLD and NASH: clinical impact. J Hepatol 2018; 68(2): 268\u2013279","journal-title":"J Hepatol"},{"issue":"1","key":"1232_CR4","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1038\/s41598-018-21939-0","volume":"8","author":"A Di Costanzo","year":"2018","unstructured":"Di Costanzo A, Belardinilli F, Bailetti D, Sponziello M, D\u2019Erasmo L, Polimeni L, Baratta F, Pastori D, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Giannini G, Del Ben M, Angelico F, Arca M. Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) by a candidate genes resequencing strategy. Sci Rep 2018; 8(1): 3702","journal-title":"Sci Rep"},{"issue":"4","key":"1232_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/hep.29273","volume":"66","author":"S BasuRay","year":"2017","unstructured":"BasuRay S, Smagris E, Cohen JC, Hobbs HH. The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation. Hepatology 2017; 66(4): 1111\u20131124","journal-title":"Hepatology"},{"issue":"3","key":"1232_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jcmgh.2021.12.008","volume":"13","author":"F Luo","year":"2022","unstructured":"Luo F, Smagris E, Martin SA, Vale G, McDonald JG, Fletcher JA, Burgess SC, Hobbs HH, Cohen JC. Hepatic TM6SF2 is required for lipidation of VLDL in a pre-Golgi compartment in mice and rats. Cell Mol Gastroenterol Hepatol 2022; 13(3): 879\u2013899","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"5","key":"1232_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/gutjnl-2020-320853","volume":"70","author":"VR Thangapandi","year":"2021","unstructured":"Thangapandi VR, Knittelfelder O, Brosch M, Patsenker E, Vvedenskaya O, Buch S, Hinz S, Hendricks A, Nati M, Herrmann A, Rekhade DR, Berg T, Matz-Soja M, Huse K, Klipp E, Pauling JK, Wodke JA, Miranda Ackerman J, Bonin MV, Aigner E, Datz C, von Schonfels W, Nehring S, Zeissig S, Rocken C, Dahl A, Chavakis T, Stickel F, Shevchenko A, Schafmayer C, Hampe J, Subramanian P. Loss of hepatic Mboat7 leads to liver fibrosis. Gut 2021; 70(5): 940\u2013950","journal-title":"Gut"},{"issue":"14","key":"1232_CR8","doi-asserted-by":"publisher","first-page":"8166","DOI":"10.1073\/pnas.1921694117","volume":"117","author":"Y Nozaki","year":"2020","unstructured":"Nozaki Y, Petersen MC, Zhang D, Vatner DF, Perry RJ, Abulizi A, Haedersdal S, Zhang XM, Butrico GM, Samuel VT, Mason GF, Cline GW, Petersen KF, Rothman DL, Shulman GI. Metabolic control analysis of hepatic glycogen synthesis in vivo. Proc Natl Acad Sci USA 2020; 117(14): 8166\u20138176","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1232_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s13238-017-0436-0","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ji X, Wang Q, Li JZ. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein Cell 2018; 9(2): 164\u2013177","journal-title":"Protein Cell"},{"issue":"1","key":"1232_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13578-020-00507-y","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Wang H. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease. Cell Biosci 2020; 10(1): 140","journal-title":"Cell Biosci"},{"issue":"4","key":"1232_CR11","doi-asserted-by":"publisher","first-page":"e16186","DOI":"10.1111\/liv.16186","volume":"45","author":"D Lind\u00e9n","year":"2025","unstructured":"Lind\u00e9n D, Tesz G, Loomba R. Targeting PNPLA3 to treat MASH and MASH-related fibrosis and cirrhosis. Liver Int 2025; 45(4): e16186","journal-title":"Liver Int"}],"container-title":["MedScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-026-1232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11684-026-1232-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-026-1232-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:50:45Z","timestamp":1789714245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11684-026-1232-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":11,"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1007\/s11684-026-1232-0","relation":{},"ISSN":["3091-4973","3091-4981"],"issn-type":[{"value":"3091-4973","type":"print"},{"value":"3091-4981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"11 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Conflicts of interest\n                      Zi-Ling Mai, Bing Chang, Yi-Ling Li, Hong Wei, and Bo-Tong Ma declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"Ethical approval was not required for this single-patient case report. The report was conducted in accordance with the principles of the Declaration of Helsinki and its later amendments. Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}